Evidence map›Paper›PMID 35407516›Full record

ArticleJournal of clinical medicine2022

Severe Pulmonary Bleeding after Assist Device Implantation: Incidence, Risk Factors and Prognostic Impact.

Bernd Panholzer, Kevin Pilarczyk, Katharina Huenges, Charlotte Aldinger, Christine Friedrich, Ulrike Nowak-Göttl, Jochen Cremer, Assad Haneya

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 67% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Bernd PanholzerDepartment of Cardiovascular Surgery, University of Schleswig-Holstein, 24105 Kiel, Germany.ORCID 0000-0002-4992-818X
Kevin PilarczykDepartment of Intensive Care Medicine, Imland Klinik Rendsburg, 24768 Rendsburg, Germany.ORCID 0000-0001-7788-1174
Katharina HuengesDepartment of Cardiovascular Surgery, University of Schleswig-Holstein, 24105 Kiel, Germany.ORCID 0000-0002-4329-9087
Charlotte AldingerDepartment of Cardiovascular Surgery, University of Schleswig-Holstein, 24105 Kiel, Germany.
Christine FriedrichDepartment of Cardiovascular Surgery, University of Schleswig-Holstein, 24105 Kiel, Germany.
Ulrike Nowak-GöttlInstitute of Clinical Chemistry, University of Schleswig-Holstein, 24105 Kiel, Germany.
Jochen CremerDepartment of Cardiovascular Surgery, University of Schleswig-Holstein, 24105 Kiel, Germany.
Assad HaneyaDepartment of Cardiovascular Surgery, University of Schleswig-Holstein, 24105 Kiel, Germany.
Christian-Albrechts-Universität zu Kiel · DEInstitut für Berufliche Aus- und Fortbildung · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Continuous flow left ventricular assist devices (CF-LVAD) improve survival in patients with advanced heart failure but confer risk of bleeding complications. Whereas pathophysiology and risk factors for many bleeding complications are well investigated, the literature lacks reports about pulmonary bleeding. Therefore, it was the aim of the present study to assess incidence, risk factors, and clinical relevance of pulmonary bleeding episodes after LVAD implantation. Methods: We retrospectively analyzed our institutional database of 125 consecutive patients who underwent LVAD implantation between 2008 and 2017. Demographic and clinical variables related to bleeding were collected. The primary endpoint was incidence of severe pulmonary bleeding (SPB). Results: Nine out of 125 patients suffered from SPB during the postoperative course (7.2%) 11 days after surgery in the median. None of them had a known history of lung disease or bleeding disorder. History of prior myocardial infarction (0% vWD. 42.2%, p = 0.012) and ischemic cardiomyopathy (25.0% vs. 50.0%, p = 0.046) were less frequent in the SBP group. Concomitant aortic valve replacement was more common in the group with SPB (33.3% versus 7.0%, p = 0.034). Surgical (blood loss 9950 vs. 3800 mL, p = 0.012) as well as ear-nose-throat (ENT) bleedings (33% vs. 4.6%, p = 0.015) were observed more frequently in patients with SPB. SPB was associated with a complicated postoperative course with a higher incidence of acute kidney failure (100% versus 36.7%, p = 0.001) and delirium (44.4% versus 14.8%, p = 0.045); a higher need for red blood cell (26 packs versus 7, p < 0.001), fresh frozen plasma (18 units versus 6, p = 0.002), and platelet transfusion (8 pools versus 1, p = 0.001); longer ventilation time (1206 versus 171 h, p = 0.001); longer ICU-stay (58 versus 13 days, p = 0.002); and higher hospital mortality (66.7% vs. 29%, p = 0.029). Conclusion: SPB is a rare but serious complication after LVAD implantation and is significantly associated with higher morbidity and mortality. The pathophysiology and potential risk factors are unknown but may include coagulation disorders and frequent suctioning or empiric bronchoscopy causing airway irritation.

Indexed as

bleedingheart failurehemoptysisLVADpulmonary hemorrhage

Identifiers

PMID35407516
PMCPMC8999887
OpenAlexW4220808471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.